Sprint Bioscience AB Statistics
Total Valuation
Sprint Bioscience AB has a market cap or net worth of SEK 86.58 million. The enterprise value is 50.57 million.
Market Cap | 86.58M |
Enterprise Value | 50.57M |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
Earnings Date | Oct 25, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Sprint Bioscience AB has 69.82 million shares outstanding. The number of shares has increased by 22.41% in one year.
Shares Outstanding | 69.82M |
Shares Change (YoY) | +22.41% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 51.99% |
Owned by Institutions (%) | 27.81% |
Float | 23.61M |
Valuation Ratios
The trailing PE ratio is 5.88.
PE Ratio | 5.88 |
Forward PE | n/a |
PS Ratio | 1.00 |
PB Ratio | 4.63 |
P/FCF Ratio | 4.18 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 3.36, with an EV/FCF ratio of 2.44.
EV / Earnings | 3.44 |
EV / Sales | 0.59 |
EV / EBITDA | 3.36 |
EV / EBIT | 3.54 |
EV / FCF | 2.44 |
Financial Position
The company has a current ratio of 1.47
Current Ratio | 1.47 |
Quick Ratio | 1.47 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 128.60% and return on invested capital (ROIC) is 78.04%.
Return on Equity (ROE) | 128.60% |
Return on Assets (ROA) | 25.05% |
Return on Capital (ROIC) | 78.04% |
Revenue Per Employee | 2.39M |
Profits Per Employee | 408,833 |
Employee Count | 28 |
Asset Turnover | 2.42 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -46.09% in the last 52 weeks. The beta is 0.50, so Sprint Bioscience AB's price volatility has been lower than the market average.
Beta (5Y) | 0.50 |
52-Week Price Change | -46.09% |
50-Day Moving Average | 1.32 |
200-Day Moving Average | 1.29 |
Relative Strength Index (RSI) | 39.94 |
Average Volume (20 Days) | 80,879 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sprint Bioscience AB had revenue of SEK 86.21 million and earned 14.72 million in profits. Earnings per share was 0.21.
Revenue | 86.21M |
Gross Profit | 66.24M |
Operating Income | 14.29M |
Pretax Income | 14.72M |
Net Income | 14.72M |
EBITDA | 15.06M |
EBIT | 14.29M |
Earnings Per Share (EPS) | 0.21 |
Balance Sheet
Cash & Cash Equivalents | 36.01M |
Total Debt | n/a |
Net Cash | 36.01M |
Net Cash Per Share | 0.52 |
Equity (Book Value) | 18.69M |
Book Value Per Share | 0.27 |
Working Capital | 14.04M |
Cash Flow
In the last 12 months, operating cash flow was 23.94 million and capital expenditures -3.21 million, giving a free cash flow of 20.73 million.
Operating Cash Flow | 23.94M |
Capital Expenditures | -3.21M |
Free Cash Flow | 20.73M |
FCF Per Share | 0.30 |
Margins
Gross margin is 76.84%, with operating and profit margins of 16.58% and 17.07%.
Gross Margin | 76.84% |
Operating Margin | 16.58% |
Pretax Margin | 17.07% |
Profit Margin | 17.07% |
EBITDA Margin | 17.46% |
EBIT Margin | 16.58% |
FCF Margin | 24.04% |
Dividends & Yields
Sprint Bioscience AB does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -22.41% |
Shareholder Yield | -22.41% |
Earnings Yield | 17.00% |
FCF Yield | 23.94% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |